WHO ICTRP trial

S.A.F.E. Study: Safety And Feasibility of Exercise for women with breast cancer

ACTRN12616000547448 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12616000547448
Public title S.A.F.E. Study: Safety And Feasibility of Exercise for women with breast cancer
Scientific title S.A.F.E. Study: Safety And Feasibility of Exercise for women with breast cancer
Primary sponsor Queensland University of Technology
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Stage II+ Breast Cancer ;Breast Cancer treatment-related sequelae; Stage II+ Breast Cancer Breast Cancer treatment-related sequelae;Cancer - Breast
Interventions Intervention: The exercise intervention will involve a minimum prescription of 150 minutes of moderate intensity aerobic- and resistance-exercise each week, with the type, intensity and duration per session individualised according to…
Registration date Apr 28, 2016
Target size 60
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations